Addressing TB involves more than just medication; it starts with conversations. Many people hesitate to begin treatment due to fear or stigma, requiring encouragement from doctors and nurses. Treating tuberculosis (TB) often starts with more than taking pills — it begins with simple conversations. Some people hesitate to start treatment, held back by fear or … Read more
Too many children with TB are neither tested nor treated, with many countries failing at the first hurdle: updating policy guidelines in line with WHO recommendations. Geneva, 15 October 2024 – A new report released today by Médecins Sans Frontières/Doctors Without Borders (MSF), shows that children with tuberculosis (TB) continue to be left behind in the … Read more
27 Sept 2024, Mumbai: Médecins Sans Frontières (MSF)/Doctors Without Borders today announced the planned closure of its Mumbai-based Drug-Resistant Tuberculosis (DR-TB) project by the end of 2024. This significant initiative has been providing comprehensive care to patients with complex cases of extensively drug-resistant TB (XDR-TB) since 2006. The project, which has played a pivotal role … Read more
10 June 2024, Mumbai: A pivotal symposium organised today by Médecins Sans Frontières (MSF)/Doctors Without Borders brought together a diverse coalition of experts and stakeholders to forge actionable strategies against Drug-Resistant Tuberculosis (DRTB). This crucial gathering aimed to highlight the key successes and challenges in the battle against TB, with an emphasis on enhancing the … Read more
Namrata’s story is a testament to the timeless principle that consistency is crucial. Her disciplined approach to maintaining a routine, embracing a healthy lifestyle, and adhering to medication regimens demonstrates that even conditions like drug-resistant tuberculosis (DR-TB) can be overcome. In 2016, Namrata was employed at a daycare in an international school in Chembur, Mumbai. … Read more
Ahmad, 11, from Tatlay Aali, a town in Gujranwala district, Pakistan, was diagnosed with tuberculosis (TB) when he was just five years old. “We’d never heard about this disease, nobody from our family ever had it. At the same time, it was very concerning especially when the doctor asked my son to wear a mask … Read more
endTB Clinical Trial Offers Multiple New Shortened Drug Regimens to Treat Adults and Children with Multidrug-Resistant Tuberculosis Paris, France; November 15, 2023 – Clinical trial results presented for the first time today at the Union World Conference on Lung Health revealed evidence to support the use of four new, improved regimens to treat multi-drug resistant … Read more
Cepheid and its parent company Danaher announced today that they are reducing the price of the Xpert MTB/RIF test for TB by 20 percent in high-TB-burden countries from US$9.98 to $7.97 per test. This reduction is a significant step, considering the corporations have refused to reduce the price of this test for over ten years. While … Read more
As Médecins Sans Frontières/Doctors Without Borders (MSF) prepares to leave the Shiselweni region after 16 years of work, its project in Nhlangano draws to a close. However, to ensure the continued success of the Shiselweni HIV & tuberculosis (TB) programme, MSF’s teams in Eswatini remain dedicated to working with the country’s Ministry of Health. To … Read more
Mumbai, 23 March 2023 – Today, the 2019 patent challenge by two tuberculosis (TB) survivors, Nandita Venkatesan and Phumeza Tisile, was successful: the Indian Patent Office rejected the US pharmaceutical corporation Johnson & Johnson’s (J&J) attempt to extend its monopoly in India on the TB drug bedaquiline beyond the primary patent’s expiry this July. Médecins … Read more